Key facts
- This page summarizes Ewon Comfortech Co., Ltd.'s Form 3 filing for Zura Bio Ltd (ZURA).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Apr 2023, 16:06.
Ewon Comfortech Co., Ltd. - 20 Mar 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ZURA
- Reported as of
- 20 Mar 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 13 Apr 2023, 16:06:16 UTC
- Next SEC filing
- 06 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ RH Lee
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ewon Comfortech Co., Ltd. filed Form 3 for Zura Bio Ltd (ZURA) on 13 Apr 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZURA
holding
Class A Ordinary Shares, par value $0.0001
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000,000
- Date
- 20 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZURA
holding
Derivative
Private Placement Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Mar 2023
- Ownership
- See footnote
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 1,653,466
- Exercise price
- $11.50
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Pursuant to that certain Subscription Agreement, dated as of June 16, 2022, as amended on November 25, 2022, between the Reporting Person and the Issuer, the Reporting Person acquired 2,000,000 Class A Ordinary Shares of the Issuer for an aggregate purchase price of $20,000,000, as an investor in the private investment in public equity investment (a "PIPE Investment") in the Issuer occurring substantially concurrently with the closing (the "Closing") of the business combination between the Issuer and Zura Bio Limited, a corporation formed under the laws of the United Kingdom and Wales ("Zura") on March 20, 2023.
Footnote F2
The Private Placement Warrants ("PPWs") of the Issuer were forfeited by JATT Ventures, L.P. and transferred to the Reporting Person on March 20, 2023. The PPWs are exercisable for $11.50 per Class A Ordinary Share commencing 30 days after the consummation of the Issuer's initial business combination, which occurred on March 20, 2023 as described in the Issuer's Current Report on Form 8-K dated March 20, 2023, and filed with the SEC on March 24, 2023.